Page last updated: 2024-10-22

amitriptyline and Disease Resistance

amitriptyline has been researched along with Disease Resistance in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Disease Resistance: The capacity of an organism to defend itself against pathological processes or the agents of those processes. This most often involves innate immunity whereby the organism responds to pathogens in a generic way. The term disease resistance is used most frequently when referring to plants.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meiners, J1
Palmieri, V1
Klopfleisch, R1
Ebel, JF1
Japtok, L1
Schumacher, F1
Yusuf, AM1
Becker, KA1
Zöller, J1
Hose, M1
Kleuser, B1
Hermann, DM1
Kolesnick, RN1
Buer, J1
Hansen, W1
Westendorf, AM1

Other Studies

1 other study available for amitriptyline and Disease Resistance

ArticleYear
Intestinal Acid Sphingomyelinase Protects From Severe Pathogen-Driven Colitis.
    Frontiers in immunology, 2019, Volume: 10

    Topics: Amitriptyline; Animals; Biomarkers; Citrobacter rodentium; Colitis; Disease Models, Animal; Disease

2019